Friday, October 10, 2025

M&B Engineering shares make quiet debut; list at par versus issue price

Date:

Shares of M&B Engineering, a company known for its steel roofing and pre-engineered building solutions, made a flat listing at Dalal Street on Wednesday, August 6.The stock listed at 386 on BSE, a miniscule premium of 0.26% over its issue price 385. On the NSE, the stock kicked-off its maiden trading session on a flat note at 385.

The listing was below grey market estimates, where shares of M&B Engineering were quoting a premium of 14.29%.

ALSO READ | NSDL shares list at 10% premium, hits day’s high of ₹920The IPO, which received a healthy subscription of 38.11 times overall. The qualified institutional buyer (QIB) segment was subscribed 38.63 times, non-institutional investors (NII) 40.22 times, and retail investors 34.36 times.
The anchor portion had earlier raised ₹291.60 crore on July 29 from institutional investors, indicating a fair level of pre-listing confidence.The ₹650 crore IPO comprised a fresh issue worth ₹275 crore and an offer for sale of ₹375 crore, with a total of 1.68 crore shares being offered to the public. Bidding took place between July 30 and August 1, and allotments were finalised on August 4.

Analysts mostly were positive on the IPO, suggesting investors to subscribe to the issue for long-term.

The fresh capital raised will go toward funding equipment and transport vehicles at manufacturing facilities, IT upgrades, debt repayment, and general corporate purposes. Proceeds from the OFS will go to the selling shareholders.

M&B Engineering operates through two business divisions—Phenix and Proflex—and offers end-to-end solutions in the pre-engineered buildings (PEB) space, including design, engineering, manufacturing, and erection.

As of March 2025, the company had completed over 9,500 projects and boasted an annual installed capacity of 103,800 metric tonnes for PEB structures and 1.8 million square metres for self-supported roofing systems.

Financially, M&B Engineering reported a 23% growth in revenue to 996.89 crore and a 69% jump in PAT to 77.05 crore in FY25 compared to the previous year. However, the company’s top line has seen some fluctuations in recent years, with FY23 revenues having dipped compared to FY22.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Blast at Tennessee explosives plant leaves multiple people dead, missing: sheriff

An explosion at a Tennessee military munitions plant left...

The ultimate guide to credit repair: Fixing your financial past

आपके क्रेडिट की मरम्मत आम तौर पर एक लंबी...

Zydus Lifesciences gets nod from Health Canada for Liothyronine tablets

Zydus Lifesciences Ltd said on Monday it has received...

Reopening of Indian Embassy in Kabul marks a major step in bilateral ties: Former Member of NSAB Tilak Devasher

The Indian government’s decision to reopen its embassy in...